SEC Filing Details

Together with patients, physicians, scientists, and industry partners we are relentlessly focused on rewriting cancer so that a diagnosis is transformed from a foregone conclusion to a more hopeful future

SEC Filing Details

Document Details

Form
4
Filing Date
Mar 3, 2020
Document Date
Feb 28, 2020
Form Description
Statement of changes in beneficial ownership of securities
Filing Group
3,4,5
Company
Five Prime Therapeutics
Issuer
FIVE PRIME THERAPEUTICS, INC.
Filer
White David
Print Page
RSS Feeds
E-Mail Alerts
Contact IR